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In Brief
The mechanisms that control bacterial
infection under hypoxic conditions are
only partially understood. Hayek et al.
show that hypoxia-mediated stabilization
of HIF1a results in the inhibition of STAT3
activation and the reduction of TCA
metabolite levels, including citrate, in
macrophages. This prevents C. burnetii
replication without reducing bacterial
viability.
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In hypoxic and inflamed tissues, oxygen (O2)-depen-
dent antimicrobial defenses are impaired due to a
shortage of O2. To gain insight into the mechanisms
that control bacterial infection under hypoxic condi-
tions, we infected macrophages with the obligate
intracellular pathogenCoxiella burnetii, the causative
agent of Q fever. Our experiments revealed that hyp-
oxia impeded C. burnetii replication in a hypoxia-
inducible factor (HIF) 1a-dependent manner. Mecha-
nistically, under hypoxia, HIF1a impaired the activity
of STAT3, which in turn reduced the intracellular level
of TCA cycle intermediates, including citrate, and
impeded C. burnetii replication in macrophages.
However, bacterial viability was maintained, allowing
the persistence of C. burnetii, which is a prerequisite
for the development of chronic Q fever. This knowl-
edge will open future research avenues on the path-
ogenesis of chronic Q fever. In addition, the regula-
tion of TCA cycle metabolites by HIF1a represents
a previously unappreciated mechanism of host de-
fense against intracellular pathogens.
INTRODUCTION
O2 levels of <1%, which can be found in inflamed and infected
tissues, are known to incapacitate key antimicrobial and immu-
nomodulating effector enzymes such as indoleamine 2,3-diox-
ygenase, phagocyte oxidase, and type 2 nitric oxide (NO) syn-
thase (NOS2), which depend on oxygen (O2) as a substrate
(Jantsch and Scho¨del, 2015). Nevertheless, bacterial infections
can be controlled in the absence of O2-dependent antimicrobial
defense (Campbell et al., 2014). Enhanced expression of anti-
microbial peptides (Peyssonnaux et al., 2005) may fulfill this3502 Cell Reports 26, 3502–3510, March 26, 2019 ª 2019 The Autho
This is an open access article under the CC BY license (http://creativetask in part and restrain the replication of pathogens, until
tissue O2 levels normalize and O2-dependent antimicrobial
effectors such as nicotinamide adenine dinucleotide phos-
phate-positive (NADPH) oxidase (PHOX) or NOS2 kick in
(Jantsch and Scho¨del, 2015). However, additional defense
strategies are likely to contribute to the control of infection un-
der hypoxic conditions. We hypothesized that the limitation of
metabolites that are essential for the proliferation of pathogens
may function as an antimicrobial effector mechanism in in-
flamed hypoxic tissue.
To test this hypothesis, we resorted to Coxiella burnetii, an
obligate intracellular pathogen and the causative agent of the
zoonotic disease Q fever (Maurin and Raoult, 1999). It is able
to withstand hypoxic conditions, and its replication in macro-
phages is only in part controlled by O2-dependent defense
mechanisms, as NOS2 and PHOX contribute to the control of
C. burnetii replication in macrophages, but macrophage lacking
NOS2 and PHOX are still able to control C. burnetii infection
(Brennan et al., 2004; Zamboni and Rabinovitch, 2003). In addi-
tion,C. burnetii requires hypoxic conditions for axenic replication
(Omsland et al., 2009). However, whether hypoxia is also
required for intracellular replication within the C. burnetii-con-
taining vacuole (CCV) is unknown.
Acute Q fever often presents as a mild flu-like illness, but inter-
stitial pneumonia or hepatitis can also be seen. The infection can
become chronic months or years after primary infection. Chronic
Q fever mainly manifests as endocarditis and is potentially fatal
(Maurin and Raoult, 1999). Interleukin 10 (IL-10) is overproduced
by the monocytes of patients with chronic Q fever (Honstettre
et al., 2003) and impairs the killing of C. burnetii in human mac-
rophages (Ghigo et al., 2001), indicating a role for IL-10 in chronic
Q fever. The immunomodulatory cytokine IL-10 deactivates
macrophages through signal transducer and activator of tran-
scription 3 (STAT3)-dependent signaling. However, the role of
STAT3 during C. burnetii infection has not been studied yet.
Here, we report hypoxia-induced hypoxia-inducible factor
1a (HIF1a) reduces the intracellular availability of Krebs cycler(s).
commons.org/licenses/by/4.0/).
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Figure 1. Hypoxia Impairs C. burnetii Replication in Macrophages
(A) Macrophages were infected with NMII for the times indicated under nor-
moxia (N) or hypoxia (H). Bacterial load was assessed by qPCR. Means ±
SEMs, n = 26, two-way ANOVA with Bonferroni post-test.
(B) Human MDM from four different donors was infected with NMII for 4 and
120 h under N or H. Bacterial numbers were determined by colony-forming unit
(CFU) counts. n = 4, Friedman test with Dunn’s post-test.
(C) Macrophages were infected with NMII for the times indicated under N,
H, or re-oxygenation after 48 h of H (H/N). Bacterial load was assessed
by qPCR. Means ± SEMs, n = 4, two-way ANOVA with Bonferroni post-
test.
(D) After 120 h, bacteria were purified and cultured in ACCM-2 for 72 h. Bac-
terial replication was assessed by optical density 600 (OD600) measurement.
Means ± SEMs, n = 5, Mann-Whitney U test.
(E) Macrophages were infected with NMII harboring an IPTG-inducible RFP
plasmid. At 120 h post-infection, IPTG was added for 8 h and the cells were
fixed and stained with DAPI and an antibody against C. burnetii. One of 3
experiments with similar results is shown.
(F) At 120 h post-infection, LysoTracker Red was added, and the cells were
stained with DAPI and with antibodies against LAMP1 andC. burnetii. One of 3
experiments with similar results is shown.
(G) At 48 h post-infection, LysoSensor dye was added, and the vacuolar pH
was measured in at least 40 CCVs in two independent experiments. Means ±
SEMs, t test.
*p < 0.05, **p < 0.01, ***p < 0.001, and ns, p > 0.05.intermediates citrate, succinate, and itaconate in macrophages
in a STAT3-dependent manner, thereby impairing the growth
but not the survival of C. burnetii in macrophages.RESULTS
Hypoxia Prevents C. burnetii Replication
To test whether hypoxia may induce O2-independent antimicro-
bial control measures, we infected macrophages withC. burnetii
Nine Mile phase II (NMII) under normoxia or hypoxia and deter-
mined the number of bacteria per macrophage by qRT-PCR of
the C. burnetii dotA and the mouse Alb1 genes. Replication of
NMII was observed only under normoxia (Figure 1A), suggesting
that hypoxia impeded bacterial replication. Human monocyte-
derived macrophages (hMDM) also allowed NMII replication
only under normoxic conditions (Figure 1B). To evaluate whether
NMII is killed by hypoxic macrophages, we reoxygenated in-
fected hypoxic macrophages, which led to the renewed replica-
tion of NMII (Figure 1C). Next, we lysed infected macrophage at
120 h post-infection to isolate and cultivate NMII in acidified cit-
rate cysteine medium-2 (ACCM-2). As shown in Figure 1D, NMII
replicated equally well, regardless of whether it was isolated
from normoxic or hypoxic macrophages, indicating that hypoxic
macrophages restricted NMII replication without killing the path-
ogen. To verify this assumption, we usedNMII carrying a plasmid
with isopropyl b-D-1-thiogalactopyranoside (IPTG)-inducible
Tag-red fluorescent protein (RFP). Macrophages infected for
120 h with NMII were treated with IPTG, and the expression of
Tag-RFP was visualized by confocal microscopy. Under both
normoxia and hypoxia, NMII was able to synthesize Tag-RFP
(Figure 1E), thus confirming that NMII remained viable in hypoxic
macrophages. These results were surprising, as C. burnetii re-
quires hypoxic conditions for axenic replication, indicating that
not O2 per se, but O2-mediated alterations, are essential for
the observed phenotype.
Hypoxia Does Not Prevent Maturation of the CCV
C. burnetii requires a phagolysosomal-like compartment for
replication (Howe et al., 2010; Schulze-Luehrmann et al., 2016).
This prompted us to characterize the CCV. By using lysosomal-
associated membrane protein 1 (LAMP-1) and LysoTracker
Red to label lysosomal compartments, we found CCVs positive
for LAMP1 and LysoTracker Red under both culture conditions.
However, the CCVs in hypoxic macrophages were much smaller
(Figure 1F). Similarly, regardless of the available O2, CCVs were
positive for DQ Red BSA, a dye that produces bright fluores-
cence only upon hydrolysis by proteases, indicating that the
CCV is a lysosomal-like compartment with degradative activity
under both hypoxic and normoxic conditions (Figures S1A and
S1B). Since replication of C. burnetii requires a pH of 4.0–5.0
(Hackstadt and Williams, 1981), we determined the pH of the
CCVs. At 48 h post-infection, it was 5.0 under both normoxia
and hypoxia (Figure 1G). Thus, the control of bacterial replication
in hypoxic macrophages is not mediated by an altered phago-
some maturation process.
Reduced IL-10 Secretion under Hypoxia Does Not
Explain the Inhibition of C. burnetii Replication
Given that the cytokine IL-10 is known to suppress important
antimicrobial effector functions and to facilitate C. burnetii repli-
cation in macrophages (Bogdan et al., 1991; Meghari et al.,
2008), we analyzed IL-10 in the supernatant of NMII-infectedCell Reports 26, 3502–3510, March 26, 2019 3503
A B C D
E F G H
Figure 2. STAT3 Signaling Is Essential for
C. burnetii Replication in Macrophages
(A) At 24 h post-infection, IL-10 levels were
analyzed by ELISA. Means ± SEMs, n = 14, t test.
(B) Infected macrophages were stimulated with
20 ng/mL IL-10. Bacterial load was analyzed by
qPCR. Means ± SEMs, n = 10.
(C and D) Uninfected cells were stimulated with (C)
0.5 ng/mL or (D) 20 ng/mL IL-10. (C) Ratio of
phosphorylated STAT3 (pSTAT3) to total STAT3
was analyzed by immunoblot. Means ± SEMs,
n = 3, t test. (D) Nuclear translocation of pSTAT3
was assessed by confocal microscopy. 200 cells
from 3 independent experiments were analyzed.
Means ± SEMs, n = 5, t test or Mann-Whitney
U test.
(E) In at least 100 infected macrophages nuclear
pSTAT3 was assessed by confocal microscopy.
Means ± SEMs, n = 3, t test.
(F) Macrophages not infected or infected with NMII
or heat-killed NMI for 24 h were subjected to
immunoblot analysis using antibodies against
pSTAT3 and STAT3. One representative immu-
noblot from three independent experiments is
shown.
(G) STAT3-deficient (STAT3D) and wild-type
(STAT3WT) macrophages were infected. Bacterial
loadwas assessedbyqPCR.Means±SEMs, n= 6.
(H) Macrophages with constitutively active STAT3
(STAT3cA) and wild-type (STAT3WT) macrophages were infected. Bacterial load was assessed by qPCR. Means ± SEMs, n = 8.
(B, G, and H) Two-way ANOVA with Bonferroni post hoc test.
*p < 0.05, **p < 0.01, ***p < 0.001, and ns, p > 0.05.macrophages. Secretion of IL-10 by infected hypoxic macro-
phages was reduced (Figure 2A). However, the addition of
IL-10 failed to restore the replication of NMII in hypoxic macro-
phages, while it boosted the growth of NMII in normoxic macro-
phages (Figure 2B). Thus, the hypoxia-induced reduction of IL-10
secretion only partially explains the inhibition of C. burnetii repli-
cation. Therefore, we hypothesized that hypoxia may specifically
interfere with IL-10 signaling.
Activation of STAT3 Is Crucial forC. burnetii Replication
IL-10 signals via the Janus kinase 1 (JAK1)/STAT3 pathway (Mur-
ray, 2006). The activation of this pathway leads to STAT3 phos-
phorylation and translocation into the nucleus (Yu et al., 2014).
The addition of IL-10 to normoxic macrophages induced the
phosphorylation of STAT3 within 10 min. Under hypoxia, the
phosphorylation of STAT3 was reduced (Figures 2C and S1C).
This difference was even more pronounced for the subcellular
localization of phosphorylated STAT3 (pSTAT3). Ten minutes
after the addition of IL-10 to normoxic macrophages, pSTAT3
was detectable in nearly 100% of the nuclei, while hardly any
hypoxic macrophages showed nuclear pSTAT3 (Figures 2D
and S1D). Similarly, the nuclear localization of pSTAT3 was
reduced in NMII-infected macrophages under hypoxia (Fig-
ure 2E). NMII, a biosafety level 2 organism, is avirulent in immu-
nocompetent mice. It was established in embryonated eggs by
the serial passage of phase I C. burnetii NM, a virulent pathogen
and a biosafety level 3 bacteria, which resulted in severely trun-
cated lipopolysaccharides (LPSs) (Howe et al., 2010). Infection
with heat-killed NMI resulted in the reduced phosphorylation of3504 Cell Reports 26, 3502–3510, March 26, 2019STAT3 under hypoxia (Figures 2F and S1E), suggesting that
the observed phenotype may also be applicable to NMI and
does not depend on LPS length.
Infection of hMDM with NMII only induced potent phosphory-
lation of STAT3 under normoxia (Figure S1F). These data sug-
gested that hypoxia impaired the activation of STAT3. Therefore,
we analyzed the role of STAT3 inC. burnetii replication by study-
ing the outcome of C. burnetii infection in STAT3-deficient
(STAT3D) or constitutively active STAT3 (STAT3cA) macro-
phages and their respective wild-type controls (STAT3WT). Under
normoxia, C. burnetii was only able to replicate in WT and in
STAT3cA macrophages, but not in STAT3D macrophages (Fig-
ures 2G and 2H), demonstrating that STAT3 activity is essential
for C. burnetii replication. Of note, in STAT3cA macrophages,
there was a pronounced C. burnetii replication under hypoxia
(Figure 2H). These data suggest that the hypoxia-induced
impairment of STAT3 activation and not the lack of O2 itself pre-
vents the proliferation of C. burnetii in hypoxic macrophages.
HIF1a and STAT3 Differently Regulate C. burnetii
Replication
HIF1a, the key regulator of cellular hypoxic responses, is known
to interfere with STAT3 signaling (Jiang et al., 2013). In addition,
HIF1a has been recognized to control key microbicidal functions
of immune cells, as it is involved in phagocytosis and bacterial
killing (Palazon et al., 2014). Therefore, we analyzedHIF1a levels.
At 24 h post-infection, neither uninfected nor NMII or heat-
killed NMI-infected macrophages showed robust stabilization
of HIF1a in the presence of ample O2. However, hypoxia induced
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Figure 3. HIF1a Regulates STAT3 Activity
and NMII Regulation under Hypoxia
(A) Ratio of HIF1a to actin was analyzed by
immunoblot. Means ± SEMs, n = 3, one-sample
t test or one-way ANOVA with Tukey post-test.
(B) Uninfected wild-type (HIF1aWT) macrophages
or macrophages deficient for HIF1a (HIF1aD) were
stimulated with 20 ng/mL IL-10 under normoxia
and hypoxia. A total of 200 cells were analyzed per
experiment for the nuclear localization of pSTAT3.
Means ± SEMs, n = 4, t test.
(C) Nuclear localization of pSTAT3 was analyzed in
100 NMII-infected macrophages from 3 indepen-
dent experiments in HIF1aWT or HIF1aD macro-
phages; t test.
(D and E) Macrophages infected with NMII were
treated with either 3 mM stattic, 0.1 mM DMOG, or
DMSO, as a control. At 24 h post-treatment STAT3
activity and HIF1a stability was analyzed by
immunoblot analysis.
(D) The ratio of pSTAT3 to STAT3 is displayed.
Means ± SEMs, n = 3, t test.
(E) Ratio of HIF1a to actin is displayed. Means ±
SEMs, n = 3, one sample t test or t test.
(F) Macrophages deficient for HIF1a (HIF1aD) or
from littermatecontrols (HIF1aWT)were infectedand
bacterial load was assessed by qPCR. Means ±
SEMs, n = 6, two-way ANOVA with Bonferroni post
hoc test.
(G) Macrophages were infected with NMII under N with or without the addition of DPI at the times indicated. Bacterial load was assessed at 120 h post-infection
by qPCR. Means ± SEMs, n = 3, one-way ANOVA with Tukey post-test.
*p < 0.05, **p < 0.01, ***p < 0.001, and ns, p > 0.05.prominent HIF1a accumulation, which was further augmented
upon infection (Figures 3A and S2A). Similar results were ob-
tained fromNMII-infected hMDM (Figure S2B). We hypothesized
that hypoxia-induced HIF1a accumulation may account for the
impaired activation of STAT3 and the lack of C. burnetii replica-
tion. To address this, we analyzed the nuclear localization of
pSTAT3 in HIF1a-deficient (HIF1aD) and controls (HIF1aWT)mac-
rophages upon stimulation with IL-10. Under normoxia, pSTAT3
was translocated into the nucleus within 10 min, regardless of
the HIF1a status (Figure 3B). In contrast, hypoxia delayed and
reduced the nuclear localization of pSTAT3 in WT macrophages
(Figures 3B and S2C). In HIF1aD macrophages, this hypoxia-
induced impairment of pSTAT3 translocation was abrogated
(Figures 3B and S2C). Similarly, the hypoxia-induced impairment
of pSTAT3 translocation was partially abolished in NMII-infected
HIF1aDmacrophages exposed to hypoxic conditions (Figure 3C).
These data suggest that HIF1a hampered the activation of
STAT3. To confirm this, we used pharmacological agents to alter
HIF1a or STAT3 activity. Treatment with dimethyloxallyl glycine
(DMOG) under normoxia led to HIF1a stabilization and reduced
STAT3 activation. In contrast, stattic inhibited the phosphoryla-
tion of STAT3 under normoxia without influencing HIF1a stabili-
zation (Figures 3D, 3E, and S2D).
From these findings, we predicted that NMII would replicate
in macrophages lacking HIF1a under hypoxic conditions. As
shown in Figure 3F, this is indeed the case. Thus, our data sug-
gest that hypoxia suppresses STAT3 activation via HIF1a and
thereby prevents the replication of NMII. NMII replication under
hypoxia in HIF1aD and STAT3cA macrophages exceeds thereplication under normoxia. To test whether this may be due to
the impaired activity of O2-dependent defense mechanisms,
we treated NMII-infected macrophages with diphenyleneiodo-
nium (DPI), which is an inhibitor of the O2-dependent antimicro-
bial effector enzymes NOS2 and PHOX. Treatment with DPI
increased the replication rates of NMII under normoxia (Fig-
ure 3G). This conforms to findings that NOS2 and PHOX are
involved in the control of C. burnetii (Brennan et al., 2004; Zam-
boni and Rabinovitch, 2003) and supports our assumption that
the increased C. burnetii replication under hypoxia in HIF1aD
and STAT3cA macrophages may be due to the shortage of O2,
which represents a critical substrate for the antimicrobial effector
enzymes NOS2 and PHOX.
HIF1a and STAT3 Differently Regulate the Intracellular
Citrate Level
Recently, it was shown that STAT3 elevates the intracellular
citrate level (Li et al., 2017) by facilitating Slc13a5-dependent cit-
rate uptake (von Loeffelholz et al., 2017) and by promoting the
expression of citrate synthase (MacPherson et al., 2017), which
suggests that STAT3 may shift metabolism toward oxidative
phosphorylation. In contrast, the lack of O2 and the consequent
stabilization of HIF1a caused a switch from oxidative phosphor-
ylation to anaerobic glycolysis (Kelly and O’Neill, 2015). Hypoxia
led to a metabolic shift toward anaerobic glycolysis during
C. burnetii infection, as indicated by the increased levels of
lactate and the reduced amounts of the Krebs cycle intermedi-
ates citrate, succinate, and cis-aconitate-derived itaconate
(Figures 4A and S3). However, in both HIF1aD macrophagesCell Reports 26, 3502–3510, March 26, 2019 3505
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Figure 4. The HIF1a and STAT3 Contrari-
wise Regulate Intracellular Citrate Levels,
and Thereby NMII Replication
(A) Citrate was extracted from infected cells and
determined by liquid chromatography-tandem
mass spectrometry (LC-MS/MS). Means ± SEMs,
n = 3, t test.
(B) Intracellular citrate levels in macrophages
deficient for HIF1a (HIF1aD) or wild-type controls
(HIF1aWT). Means ± SEMs, n = 3, t test.
(C) Gene expression of murine citrate synthase
was determined by qRT-PCR. The data are shown
as means ± SEMs of DDCT values (using hypo-
xanthine phosphoribosyltransferase [HPRT] as a
calibrator), two-way ANOVA with Bonferroni post-
test. n = 3.
(D) Infected macrophages were treated with
0.1 mM CTP inhibitor (CTP-I) or left untreated. The
bacterial load was assessed by qPCR. Means ±
SEMs, n = 6, two-way ANOVA with Bonferroni
post hoc test.
(E and F) Infected macrophages were treated with
1 mM trimethylated citrate (TMC). (E) The bacterial
load was assessed by qPCR or (F) cells were
stained with DAPI (blue) and an antibody against
C. burnetii (red). Means ± SEMs, n = 6, two-way
ANOVA with Bonferroni post hoc test.
(G–I) Gene expression of C. burnetii 2-methylcitrate dehydratase (prpD) (G), isocitrate dehydrogenase (icd) (H), and citrate synthase (gltA) (I) was determined by
qRT-PCR. Means ± SEMs of DDCT values (using IS1111 as a calibrator), one-sample t test. n = 3.
*p < 0.05, **p < 0.01, ***p < 0.001, and ns, p > 0.05.(Figure 4B) and STAT3cA macrophages (Figure S2E), but not
in STAT3D macrophages (Figure S2F), hypoxia failed to reduce
citrate levels, indicating that HIF1a antagonized STAT3-induced
Krebs cycle intermediate availability in infected macrophages
under hypoxia. Under normoxia, neither HIF1a deficiency nor
STAT3 deficiency resulted in altered citrate levels (Figures 4B
and S2F), suggesting the neither HIF1a nor STAT3 controls
metabolic processes in the presence of ample O2.
In the following, we concentrated on the investigation of the
role of citrate as one example of an HIF1a- and STAT3-regulated
metabolite. Thus, to identify a possible underlying mechanism
for the decreased availability of citrate under hypoxia, we
analyzed the mRNA expression level of the murine citrate syn-
thase (Cs). We detected an infection-dependent upregulation
of Cs. However, under hypoxia, the expression of Cs was
reduced (Figure 4C), supporting our conclusion that HIF1a
antagonizes STAT3-induced activities. The upregulation of Cs
may cause the observed increase in citrate levels during infec-
tion (Figure S3).
The axenic growth medium, which allows extracellular
C. burnetii replication, contains high levels of citrate. If impaired
replication ofC. burnetii under hypoxia were due to a reduction in
citrate levels, then pharmacological inhibition of the mitochon-
drial citrate transport protein (CTP) should abolish bacterial repli-
cation. The addition of CTP inhibitor prevented NMII replication
under normoxia (Figure 4D), suggesting that mitochondrial func-
tion and mitochondrial-derived metabolites play an important
role in C. burnetii replication. Next, we asked whether supple-
mentation of hypoxic NMII-infected macrophages with citrate
abrogates the inhibition of replication. Thus, NMII-infected hyp-3506 Cell Reports 26, 3502–3510, March 26, 2019oxic macrophages were treated with trimethylated citrate (TMC),
a membrane-permeable form of citrate. Treatment with TMC led
to the strong replication of NMII under hypoxia (Figures 4E and
4F). Whether this is a direct or indirect effect of TMC must be
determined. These data indicate that hypoxia impedes STAT3
activation via HIF1a and thereby reduces the intracellular avail-
ability of citrate and containment of C. burnetii.
In addition to the increased expression of the host cell citrate
synthase during C. burnetii infection (Figure 4C), we observed
that the bacterium adjusts the transcription of its own genes
involved in citrate metabolism. Thus, the expression of proteins
consuming citrate was downregulated under hypoxia (Figures
4G and 4H), while the expression of proteins participating in
the production of citrate was upregulated (Figure 4I).
The HIF1a-STAT3-Citrate Axis Is Functional in
Legionella pneumophila-Infected Macrophages
Next, we analyzed whether the HIF1a-STAT3-citrate axis is also
operational during infection with L. pneumophila, the etiological
agent of Legionnaires’ pneumonia. We used L. pneumophila
DflaA, a flagellin-deficient strain, which does not induce Toll-
like receptor 5 (TLR5) and MyD88 signaling (Bartfeld et al.,
2009). Hypoxia prevents the replication of L. pneumophila
DflaA (Figures S4A and S4B), indicating that hypoxia-induced in-
hibition of bacterial replication is not C. burnetii specific. The
infection of macrophages with L. pneumophila also induced
potent phosphorylation of STAT3 under normoxia (Figure S4C).
In addition, L. pneumophila-infected macrophages did not
show robust stabilization of HIF1a in the presence of ample
O2. However, hypoxia triggered prominent HIF1a stabilization
that was augmented by infection (Figure S4D). Furthermore,
infection with L. pneumophila resulted in the upregulation of cit-
rate only in the presence of ample O2 (Figure S4E). In contrast to
the situation during C. burnetii infection, neither genetic ablation
of HIF1a nor treatment with CTP inhibitor (CTP-I) or TMC
rescued L. pneumophila replication (Figures S4F and S4G).
These experiments demonstrate that although the HIF1a-
STAT3-citrate axis is operational during L. pneumophila infec-
tion, neither HIF1a nor citrate is decisive for L. pneumophila
intracellular replication.
DISCUSSION
O2 availability in the microenvironment has a critical impact on
immune responses (Jantsch and Scho¨del, 2015; Taylor and Col-
gan, 2017). The key transcription factor regulating O2 homeosta-
sis is HIF1a (Fuhrmann and Br€une, 2017). Here, we provide
evidence that hypoxia restrains the intracellular growth of
C. burnetii by limiting intracellular citrate levels (Figures 1A, 1B,
4A, 4D, and 4E). However, suppression of bacterial replication
by the reduction of tricarboxylic acid (TCA) cycle intermediates
did not lead to the elimination of C. burnetii in macrophages.
Instead, the bacteria persisting in hypoxic macrophages re-
mained fully viable (Figures 1C–1E). Our discovery that this state
of persistence was elicited by hypoxia via the induction of HIF1a
(Figure 3F), the suppression of STAT3 (Figures 2G and 2H), and
the restriction of TCA cycle metabolites (Figures 4A and S3)
establishes a hitherto unknown link between the tissue microen-
vironment and the host cell metabolism, which is of principal
relevance for the understanding of pathogen control and
evasion. Our data suggest that citrate depletion is critically
involved in this state of affairs. However, it is unclear whether cit-
rate depletion on its own or alterations in host and/or pathogen
metabolism induced by citrate limitation mediate the restriction
of C. burnetii replication.
Information about the trigger(s) and site(s) ofC. burnetii persis-
tence is rare. Our results suggest that C. burnetii, although
contained, may persist in hypoxic tissues. Previous reports
suggested that C. burnetii may hide either in the bone marrow
(BM) or in adipose tissue (Bechah et al., 2014; Harris et al.,
2000). As O2 levels in the BM of rodents range from 0.6% to
2.8% O2 (Spencer et al., 2014), the BM may provide a niche
that facilitates the persistence ofC. burnetii. Similarly,Mycobac-
teria tuberculosis survives within granulomas, in which hypoxia
induces a state of dormancy (Belton et al., 2016; Wayne and
Hayes, 1996).
Infection with various pathogens and macrophage stimulation
with pathogen-associated molecular patterns (PAMPs) results in
the accumulation of HIF1a, even in the presence of ample O2.
Normoxic HIF1a stabilization requires nuclear factor (NF)-kB
activation (Rius et al., 2008) and involves transcriptional and
posttranslational signaling events (Tannahill et al., 2013). Several
studies have demonstrated that the accumulation of HIF1a is
required to promote innate antimicrobial defenses (Palazon
et al., 2014).
However, under normoxic conditions, C. burnetii fails to
induce this inflammatory HIF1a activation (Figures 3A, S2A,
and S2B), suggesting that C. burnetii has evolved strategiesto prevent hypoxia-independent HIF1a activation. In contrast,
M. tuberculosis infection leads to an increase in HIF1a protein
level and to a switch toward aerobic glycolysis under normoxia
(Shi et al., 2015). Similarly, infection with Chlamydia trachoma-
tis and Anaplasma phagocytophilum results in a metabolic shift
toward aerobic glycolysis, which is linked to HIF1a (Cabezas-
Cruz et al., 2017; Rother et al., 2018). In agreement with the
above-mentioned ability of C. burnetii to prevent HIF1a stabi-
lization on its own in the presence of O2, we only detect a
switch toward glycolysis during NMII infection under hypoxia
(Figure S3).
STAT3 signaling is essential for the anti-inflammatory response
(Murray, 2006). Recent evidence demonstrates that STAT3 is
also involved in metabolism, as it controls the expression of the
citrate transporter Slc13a5 (von Loeffelholz et al., 2017) and
citrate synthase (MacPherson et al., 2017). In line with these
findings, we found that the increased expression of citrate syn-
thase correlates with increased STAT3 activity (Figure 4C).
HIF1a, in contrast, facilitates the switch fromoxidative phosphor-
ylation to glycolysis and inhibits the Krebs cycle (Kelly and
O’Neill, 2015). This leads to reduced levels of acetyl coenzyme
A (CoA), which cannot be processed to citrate any longer (Kim
et al., 2006). Overall, both STAT3 and HIF1a regulate the intracel-
lular citrate level, but in opposite directions. Accordingly, we
found that during C. burnetii and L. pneumophila infection,
STAT3 activity increased the intracellular citrate level, while
HIF1a activity prevented the elevation of citrate levels. This regu-
latory system is only operational under hypoxia, but not under
normoxia.
Citrate, the first intermediate of the Krebs cycle, plays an
important role in immunity. For instance, citrate is required
for fatty acid biosynthesis, which is involved in mounting an
appropriate immune response (Moon et al., 2015). Moreover,
citrate can be converted via cis-aconitate to itaconate, which
possesses antimicrobial and anti-inflammatory potential (Mi-
chelucci et al., 2013). Thus, citrate is thought to form a building
block for the production of inflammatory mediators and antimi-
crobial molecules. However, high levels of citrate may also
entertain the proliferation of C. burnetii (Omsland et al.,
2008), which is likely to counteract the positive effects of cit-
rate on microbial defense. Citrate is not only important in im-
munity but also in cancer, as it provides an important source
of carbon (Hatzivassiliou et al., 2005; Mycielska et al., 2018).
Of note, several cancers are characterized by HIF1a stabiliza-
tion, which impedes citrate production through oxidative meta-
bolism. Thus, there are remarkable parallels in the regulation of
cellular metabolism in immunity and cancer with respect to
citrate limitation. However, tumor cells may escape citrate lim-
itation by the use of the reductive carboxylation pathway (Wise
et al., 2011); C. burnetii is apparently unable to compensate for
this limitation.
Not only the infection with C. burnetii and L. pneumophila
(Figure S3) but also the infection with Chlamydia trachomatis
caused an increase in citrate levels (Rother et al., 2018), sug-
gesting that bacterial sensing by the host cell may induce a
switch in metabolism to fight against invading pathogens. How-
ever, in contrast to L. pneumophila, C. burnetii may require
citrate for replication, suggesting that this host cell defenseCell Reports 26, 3502–3510, March 26, 2019 3507
mechanism is counterproductive during C. burnetii infection.
How C. burnetii benefits from citrate is unknown at present. It
was shown that Staphylococcus aureus is able to sense host
cell citrate and subsequently to adjust the expression of
virulence genes in addition to metabolism (Ding et al., 2014). It
remains to be elucidated whether host cell levels of citrate do
indeed not only affect the expression of metabolic genes (Fig-
ures 4G–4I) but also of virulence factors.
In conclusion, we have demonstrated that under hypoxia,
HIF1a prevents the activation of STAT3 in macrophages, which
in turn results in the reduced availability of the Krebs cycle in-
termediates succinate, itaconate, and citrate. The lack of these
TCA cycle metabolites is linked to the shutdown of C. burnetii
replication, while it simultaneously induces a state of persis-
tence, which may be important for the establishment of
chronic Q fever. These findings demonstrate that the regula-
tion of TCA cycle metabolites by innate HIF1a signaling repre-
sents a principle of nutritional pathogen containment under
hypoxia.
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AxioVision 4.8 Carl Zeiss https://www.micro-shop.zeiss.com/
de/de/system/software+axio+vision-
mehrfachlizenzen+biomed-axiovision+
software/10226/
GraphPad Prism 5 GraphPad Software https://www.graphpad.com/scientific-
software/prism/CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Anja
L€uhrmann (anja.luehrmann@uk-erlangen.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
C57BL/6 wild-type mice were obtained from Charles River Breeding Laboratories (Sulzfeld, Germany). To obtain mice deficient in
HIF1a in their myeloid cell compartment (HIF1aDmyel), HIF1aflox/flox mice were crossed with lysozyme M-driven Cre (LysMCre)-trans-
genic mice (Clausen et al., 1999), both on a C57BL/6 background, as previously published (Schatz et al., 2016). C57BL/6 mice defi-
cient in functional STAT3 (STAT3Dmyel) in the myeloid cell compartment were generated by crossing of LysMCre mice to STAT3flox
mice (Takeda et al., 1998). C57BL/6 mice with myleoid-specific constitutive activation of STAT3 (STAT3cAmyel), R26Stat3Cstopfl/fl
mice (Fogli et al., 2013) were crossed with LysMCre mice. All mice utilized in this study were male animals at least six weeks of age.
Murine bone marrow derived macrophages
To generate primary bone marrow derived macrophages (MF), femoral and tibial bone marrow cavities were flushed. The cells were
propagated in Teflon bags (Angst+Pfister, #01.1425.0130) containing Dulbecco’s modified Eagle’s medium (DMEM), 10% Fetal Calf
Serum (FCS), 5% Horse Serum and 20% supernatant of L929 cells for 7-9 days at 37C, 10% CO2 and 21% O2.
Human peripheral blood derived macrophages
Human peripheral blood was obtained from four healthy donors (Ethical Committee Erlangen approval number 111_12B). Donor 1
was a 42 year old male, donor 2 was a 62 year of male, donor 3 was a 26 year old female, donor 4 was a 38 year old male. Monocytes
were obtained as described elsewhere (Ostrop et al., 2015). Briefly, PBMC were isolated from leukoreduction system chambers by
density centrifugation. Monocytes were then positively selected using anti-CD14 microbeads (Miltenyi Biotec). For culture, RPMI
1640 medium was supplemented with 10% (v/v) FCS and penicillin/streptomycin. Monocytes were differentiated into macrophages
using 50 U/ml M-CSF (Peprotech) at a density of 10 3 106 cells for 7 days without change of media at 37C, 5% CO2 and 21% O2.
Cells were washedwith PBS, detachedwith accutase, carefully scraped off and pooled. Next, they were centrifuged, resuspended in
RPMI-CM (described below), counted and seeded.
Coxiella burnetii
C. burnetii NMII strain clone 4 (RSA439) was generously provided by Matteo Bonazzi (CNRS Montpellier, France). C. burnetii NMII
was propagated for 5 days in ACCM-2 at 37C, 5% CO2, and 2.5% O2. C. burnetii NMII was heat killed at 70C for 30 min under
shaking at 500 rpm. C. burnetii NMI strain (RSA493) was heat killed at 70C for 60 min under shaking at 500 rpm.
Legionella pneumophila
The flagellin-deficient strain of L. pneumophila flaA (DflaA) was used as described elsewhere (L€uhrmann et al., 2010). In short, from a
single colony of L. pneumophila, a 2-days heavy patch was performed on a BCYE agar plate, which was incubated at 37C, 5%CO2,
and 21% O2.
METHOD DETAILS
Cell culture
Infected MFwere cultured at 37C, 5%CO2, 21%O2 (normoxia, N) or at 37C, 5%CO2, 0.5%O2 (hypoxia, H). Hypoxic experiments
were conducted in InvivO2 hypoxic chamber (Baker Ruskinn, Bridgend, UK). Buffers and media were equilibrated for at least 4 h
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Infection
MF were harvested, seeded and cultured at N in RPMI 1640 complete medium (RPMI-CM) containing 10% FCS, 1% HEPES and
0.5% b-mercaptoethanol. Prior to infection, C. burnetii were quantified by measuring the optical density at OD600, where an
OD600 of 1 equals 1 3 10
9 C. burnetii. The cells were infected with C. burnetii at MOI 10. Following infection, cells were centrifuged
for 5 min at 250 x g and placed under N or H. After 4 h of infection, cells were washed with PBS and supplied with RPMI-CM.
Prior to infection with L. pneumophila, they were scraped off the plate, resuspended in PBS and then quantified by measuring the
optical density at OD600, where an OD600 of 1 equals 1 3 10
9 L. pneumophila.
Treatment with chemicals
After infection as described above, fresh RPMI-CM was added with or without the following chemicals. The mitochondrial citrate
transport protein inhibitor (CTP-I) (SML0068, Sigma-Aldrich, Germany) was used at 0.1 mM. Trimethyl citrate (TMC) (27502,
Sigma-Aldrich) was added at 1 mM. Stattic (STAT3 inhibitor V, #202818, Santa Cruz Biotechnology, USA), the control DMSO
(D5879, Sigma-Aldrich), or the inhibitor DMOG (D3695, Sigma-Aldrich, Germany) were added at the indicated concentrations. Diphe-
nyleneiodonium chloride (DPI) (D2926, Sigma-Aldrich), an inhibitor of NOS2 and PHOX, was used at 500 nM.
DNA purification
MF were detached using cell scrapers and pelleted at 500 x g for 10 min using a centrifuge pre-cooled to 4C. Supernatent
was removed and 500 ml lysis buffer (0.1 M EDTA, 100 mM NaCl, 10% SDS, 50 mM Tris-HCl pH 8.0) containing 0.2 mg/ ml
Proteinase K were added. Cells were lysed over-night in a thermo shaker at 1000 rpm and 55C. To remove cell detritus, reaction
tubes were subsequently centrifuged 10 min at 20,000 x g and ambient temperature. Supernatants were transferred to new tubes
and DNA in solution was precipitated by addition of 1 volume isopropanol (500 ml). DNA was pelleted at 20,000 x g and 4C, washed
two times with 1 mL 70% ethanol, and air-dried. Pellets were resuspended in 100 ml ultrapure H2O.
Quantification of C. burnetii load
We defined the ratio of C. burnetii genomic copies to MF genomic copies as bacterial load per cell. C. burnetii genomes were quan-
tified from isopropanol-precipitated DNA samples by qPCRwith a primer set specific for the dotA gene. PurifiedC. burnetiiNMII DNA
in the range of 103 to 109 genome copies was used as template to generate standard curves (Schulze-Luehrmann et al., 2016). MF
genomic copies were quantified from the same sample using a primer set specific for the murine alb1 gene (exon 7). Isopropanol-
purified DNA from 1x108 MFwas diluted 10-fold down to 10 by serial dilution and served as a template to generate standard curves.
qPCRwas carried out with 5x QPCRMixEvaGreen (Rox) (Bio&Sell, F€urth, Germany), a 0.1 mMfinal concentration of each primer, and
2 mL isolated DNA (diluted 1:20 in ultrapure H2O) as template in a final volume of 10 mL per reaction.
Colony-forming units
C. burnetii-infected human MF or L. pneumophila-infected MFwere washed with PBS and lysed with ice-cold H2O for 40 min. Next,
the cells were pipetted repeatedly with a syringe carrying a 25G needle (25 G 1’’ 0,5 3 25 mm, BD Microlance 3, Spain) to lyse the
remaining cells. The suspension was then centrifuged for 10 min at 1000 rpm, 4C. The supernatant was centrifuged for 1 min at
14000 rpm, 4C. Next, the pellet was resuspended in 200 uL PBS pH 7.4. A serial dilution was performed and the diluted
C. burnetii or L. pneumophila were pipetted in triplicates on ACCM-D/0.5% agarose plates or BCYE-agar plates, respectively.
C. burnetii-plates were incubated for 2 weeks at 37C, 5% CO2 and 2.5% O2 while L. pneumophila for 3 days at 37C, 5% CO2
and 21%O2. CFUs were counted and calculated considering the dilution factors to meet the actual amount per one well.
Analysis of IL-10
Secretion of IL-10 by C. burnetii infected MF was measured in cell culture supernatants by ELISA (BD Biosciences, Heidelberg,
Germany).
RNA
For each RNA sample, 2x106 infected MF were harvested at indicated time points. Medium was removed and cells were washed
1x with PBS. 1 mL peqGOLD TriFast (30-2010, Peqlab VWR, Belgium) was added to the wells. Homogenization, phase separation,
RNA precipitation, RNA wash and RNA solubilization were performed according to the manufacturer’s protocol. Pellets were
resuspended in 50 ml RNase- free H2O and stored at 80C.
Isolated RNA were treated with DNase and RDD buffer (79254, QIAGEN, Hilden, Germany) for 10 min at 37C. DNase was
inactivated at 75C for 5 min. Contamination with genomic DNA was checked via PCR and subsequent loading on a 2% agarose
gel. No contamination was detected.
DNase-treated RNA was used to synthesize first strand cDNA using SuperScript II Reverse Transcriptase according to the
manufacturer’s protocol (18064-022, Invitrogen by Life Technologies, Carlsbad, USA).
qPCR was performed using the QuantiFast SYBR Green PCR Kit (204054, QIAGEN, Hilden, Germany), a 100 nM final concentra-
tion of each primer and 2 mL of 5-fold diluted cDNA as template in a final volume of 10 mL per reaction. Primers used for murine MF
were Hprt1 (used as a housekeeping gene) and citrate synthase. Primers used for C. burnetii are IS1111 (used as a housekeepinge4 Cell Reports 26, 3502–3510.e1–e6, March 26, 2019
gene), 2-methylcitrate dehydratase prpD, NADP-dependent isocitrate dehydrogenase icd, and citrate synthase gltA. Primer
sequences are listed in the key resources table. The quantification of the expression levels of the stated genes was referenced to
the respective housekeeping gene and normalized to the mentioned normoxic sample. The 2-(DDCT) method was used to calculate
the fold change.
STAT3 immunoblot
For the IL-10 stimulated MF, MF were seeded and cultured for 2 h at 37C, 5% CO2, 21% O2 (N) or at 0.5% O2 (H). Next, the cells
were stimulatedwith 0.5 ng /ml rmIL-10 (417-ML, R&D systems,Wiesbaden, Germany) for the indicated time points. MF, whichwere
infected with C. burnetii, were prepared as explained before. Samples were washed with PBS and harvested with 2 x Laemmli SDS
loading buffer (250 mM Tris-HCl pH 6.8, 8% SDS, 40% Glycerin, 8% b-mercaptoethanol, and 0.02% Bromophenol blue) and sub-
sequently incubated for 5 min at 95C, shaking at 450 rpm. Equal amounts of proteins were separated by SDS-PAGE and transferred
to a PVDFmembrane (MerckMillipore, Darmstadt, Germany). Themembranes were probedwith antibodies directed against pSTAT3
and STAT3 from Cell Signaling (Frankfurt, Germany). The proteins were visualized by using horseradish peroxidase-conjugated
secondary antibodies (Dianova, Hamburg, Germany) and a chemiluminescence detection system (Thermo Fisher Scientific,
Waltham, MA, USA).
HIF1a immunoblot
For probing HIF1a, the cells were lysed with 10 mM Tris-HCl pH 6.8, 6.65 M Urea, 10% Glycerin, 1% SDS with freshly added 1 mM
DTT and complete proteinase inhibitory mix (Roche complete mini, EDTA free / Roche, Mannheim, Germany). Before loading equal
amounts of proteins the lysed sampleswere adjustedwith 4 x Laemmli SDS loading buffer and incubated for 8min at 85C, shaking at
450 rpm. Themembranes were probedwith antibodies directed against HIF1a (Cayman 10006421/ Biomol, Hamburg, Germany) and
Actin (A 2066) from Merck Sigma-Aldrich (Darmstadt, Germany). The proteins were visualized by using horseradish peroxidase-
conjugated secondary antibodies (Dianova, Hamburg, Germany) and a chemiluminescence detection system (Thermo Fisher
Scientific, Waltham, MA, USA).
Immunofluorescence
For indirect immunofluorescence microscopy analyses,C. burnetii infected MFwere cultured on 10mm coverslips in 24-well dishes.
At indicated points of time, cells were fixed for 15 min with 4% paraformaldehyde (PFA), permeabilized 1 min with ice-cold methanol
and quenched and blocked for 30 min with 50 mM NH4Cl in PBS/ 5% goat serum (GS). After incubation with primary and secondary
antibodies dilution in PBS/ 5% GS the coverslips were mounted using ProLong Diamond containing DAPI (Invitrogen). For visualiza-
tion, a Carl Zeiss LSM 700 Laser Scan Confocal Microscope and the ZEN2009 software (Jena, Germany) were used.
In this study, we used primary antibodies directed against C. burnetii, LAMP-1 (Developmental Studies Hybridoma Bank, Iowa, IA,
USA), and phosphorylated STAT3 (Cell Signaling, 9145). Secondary antibodies were Alexa Fluor labeled (Alexa Fluor 488 and 594)
and purchased from Dianova, Hamburg, Germany. To detect acidic cell compartments, infected MF were incubated with
equilibrated 1 mM LysoTracker Red DND-99 (Life Technologies) diluted in RPMI-CM one hour prior to fixation. As a phagolysosomal
marker, DQ-Red BSA (Life Technologies) was used at a concentration of 2 mg/ml and incubated with the infected MF 4 hours prior to
fixation.
TagRFP assay
To assess viability of intracellular C. burnetii, MF were infected with C. burnetii NMII strain harboring an IPTG-inducible TagRFP. At
120 h post-infection, 3 mM IPTG (ThermoFisher) was added. After an additional 8 h, cells were stained for indirect immunofluores-
cence microscopy as described.
Ratiometric pH measurements
One day prior to harvestingC. burnetii expressing IPTG-inducible TagRFP, 3mM IPTGwas added to the ACCM-2medium. 1x106MF
were seeded in 35-mm glass bottom culture dishes (Mat Tek, Ashland, MA, USA). Cells were infected with C. burnetii expressing
IPTG-inducible TagRFP atMOI 20 and cultured for 48 hours. Hypoxic samples werewashed and incubated inside a hypoxic chamber
that can be mounted on the ApoTome (Zeiss) and subsequently sealed air tight before image acquisition. After washing with
equilibration buffer (5 mm NaCl, 115 mm KCl, 1.2 mm MgSO4, 25 mm MES; pH 6.0) the cells were incubated in 2 mm Lysosensor
Yellow/Blue DND-160 (Life Technologies) in equilibration buffer and life cell images were acquired between 1-15 min after addition
of the dye with an ApoTome (Zeiss) and AxioVision 4.8 software. Cells were excited with 365 nM and the emission filters were 445 nM
(B, less acidic) and 510 nM (Y; more acidic). Mean pixel values of fluorescence intensities of regions of interest (ROIs, 10 mm2)
corresponding to CCVs (red fluorescence) were measured using AxioVision 4.8 software. Yellow to blue ratio of fluorescence
intensities was further used to calculate vesicular pH employing the potential fit parameters from the calibration curve. To calibrate
Lysosensor Yellow/Blue DND-160 emission ratios for a range of pH values in situ, cells were incubated before addition of the dual-
wavelength fluorophore for 15 min with equilibration buffer of known pH (3.0-7.5) in the presence of 10 mM Monensin and 10 mM
Nigericin. Monensin is a Na+/H+ antiporter whereas Nigericin is a K+/H+ antiporter, thus bringing the cytosol and CCVs to the pH
of the surrounding medium. A standard curve was generated in GraphPad Prism to assign a predicted pH for relevant Y/B values.Cell Reports 26, 3502–3510.e1–e6, March 26, 2019 e5
An independent standard curve was generated on each experimental day. Yellow/blue values from duplicates of at least 19 individual
cells in two independent experiments were averaged for the analysis.
GC-MS
Infected MF were lysed with ice-cold 80% methanol and frozen immediately at 80C. During lysis, 10 mL of an internal standard
solution containing 13C3-lactate,
13C3-pyruvate,
13C4-succinate,
13C4-fumarate, malate-d3, and citrate-d4 (1 mM each) was added.
For further sample preparation, samples were thawed, vortexed, centrifuged (9560 x g, 6 min, 4C) and the extract was collected.
The cell pellet was washed twice with 80% methanol and the extracts were combined and dried in a vacuum evaporator
(CombiDancer, Hettich AG, Ba¨ch, Switzerland). Carboxylic acid analysis was performed by GC-MS after methoximation and
silylation employing the derivatization protocol and instrumental setup recently described (Dettmer et al., 2011). An injection volume
of 1 mL and splitless injection was used. Quantification was performed using a calibration curves with the stable isotope labeled
compounds as internal standard. 13C4-Fumarate was used as internal standard for itaconate. It should be noted that citrate and
isocitrate are not chromatographically resolved by the employed method. But, the LLOQ for isocitrate is higher than for citrate
and screening for a m/z value specific for isocitrate did not reveal noticeable detection of isocitrate. Intracellular metabolite amounts
were normalized to protein amount. The protein pellet was lysed in a NaH2PO4 buffer (20 mMwith 1.2%SDS) and the protein amount
was measured using the FluoroProfile protein Quantification Kit (Sigma Aldrich, Taufkirchen, Germany) or the Purple Protein
Quantification Assay (Serva).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was conducted with Prism 5 (GraphPad software) and Excel (Microsoft). Statistical details can be found in the
legends of the figures. Normality distribution was tested with D’Agostino & Pearson normality test or the Kolmogorov-Smirnov
test, or, when N < 8, Shapiro-Wilk normality test or the Kolmogorov-Smirnov test. For non-normally distributed datasets, the
Mann-Whitney test and Friedmann test with Dunns post-hoc test was used. Otherwise, two-way ANOVA with a Bonferroni post
hoc test, one-way ANOVA with Tukey post hoc test, or the unpaired two-tailed Student’s t test was used. The Welch’s correction
was used if unequal variances were detected. One-sample t-test was used when comparing datasets to normalized values. A value
of p < 0.05 was considered significant.e6 Cell Reports 26, 3502–3510.e1–e6, March 26, 2019
